Recently, Dong Xiao et al. found that SPHK2, a direct target of miR-708, triggered a cascade of signals leading to the activation of Akt pathway and the phosphorylation of GSK-3β and finally to the nuclear translocation of β-catenin to regulate EMT in glioma cells [35]. This evidence concerns the gene SPHK2 and central nervous system cancer.